Levmentin

Amoxicillin and clavulanic acid, the active ingredients in Levmentin, constitute a Penicillin beta‑lactam antibiotic presented as an injectable solution for intravenous use. This combination targets a broad spectrum of bacterial pathogens and is employed to treat serious infections such as community‑acquired respiratory, urinary, skin, intra‑abdominal and other severe bacterial conditions in both adult and pediatric patients.

GNH USA supplies Levmentin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Levmentin (amoxicillin and clavulanic acid) is used to treat bacterial infections across several organ systems.

- Community‑acquired respiratory tract infections: reduces bacterial load and improves clinical symptoms. - Urinary tract infections: eradicates common uropathogens and resolves infection signs. - Skin and soft‑tissue infections: combats Staphylococcus and Streptococcus species causing cellulitis and abscesses. - Intra‑abdominal infections: provides coverage for mixed aerobic and anaerobic organisms. - Severe bacterial infections requiring IV therapy: delivers rapid, high‑concentration drug levels for critically ill patients.

Levmentin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: often self‑limiting, may be watery. - Rash: maculopapular skin eruption. - Injection‑site pain: localized discomfort after IV administration. - Elevated liver enzymes: transient increase in ALT/AST. - Headache: mild, transient.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: severe skin and mucous membrane involvement. - Clostridioides difficile‑associated colitis: severe diarrhea with pseudomembranous colitis. - Hepatic dysfunction: jaundice, hepatitis. - Neutropenia or agranulocytosis: marked reduction in white blood cells. - Seizures: rare, especially in patients with renal impairment or high doses.

Before initiating therapy, clinicians should consider several safety aspects.

- Allergy assessment: verify no known hypersensitivity to penicillins or β‑lactamase inhibitors. - Liver function monitoring: check baseline transaminases and repeat if clinically indicated. - Renal dose adjustment: reduce dosage in patients with moderate to severe renal impairment. - Pregnancy safety: category B; use only if benefits outweigh potential risks. - Contraindication in severe hypersensitivity: avoid in patients with a history of anaphylaxis to β‑lactams. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levmentin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Probenecid: decreases renal excretion of amoxicillin, increasing plasma concentrations and risk of toxicity. - Methotrexate: may reduce clearance of methotrexate, heightening hematologic and hepatic toxicity.

Moderate Interactions (Monitor Closely): - Oral anticoagulants (e.g., warfarin): may enhance anticoagulant effect; monitor INR. - Oral contraceptives: antibiotics can reduce contraceptive efficacy; advise backup method. - Allopurinol: increased risk of rash; monitor skin reactions.